COMMUNIQUÉS West-GlobeNewswire

Anne ABRIAT-HEMMENDINGER appointed to the Board of Directors of DEINOVE
21/05/2019
Her proven experience in the beauty industry, particularly within the L'Oréal Group, will be a key asset in DEINOVE's innovation approach This appointment underlines the importance of the bioactive compounds and the [...]
Curetis to Receive Additional EUR 6.5 Million Financing from EIB and Yorkville
21/05/2019
- Curetis and EIB agree on equity-linked participation upon maturity of new EUR 5 million tranche of debt financing - Yorkville to provide funding of EUR 1.5 million to Curetis Amsterdam, the Netherlands, and [...]
Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which Amryt Pharma Plc Will Acquire 100% of Reorganized Stock of Aegerion
21/05/2019
Transaction is result of comprehensive capital structure and strategic review conducted independently by both Novelion’s and Aegerion’s Boards of Directors Aegerion will continue to make available to patients its two [...]
AIT Therapeutics Presents Data at the 2019 American Thoracic Society Conference in Dallas, TX
21/05/2019
Oral presentation part of a mini-symposium on NTM held on Monday, May 20, 2019 GARDEN CITY, N.Y. and REHOVOT, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical [...]
Pacific Health Care Organization, Inc. First Quarter 2019 Results
21/05/2019
Newport Beach, CA, May 20, 2019 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its quarterly report [...]
Akers Biosciences Reports Q1 2019 Earnings
20/05/2019
Continued Progress Toward Positioning the Company for Strategic Alternatives THOROFARE, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the “Company”), a developer of rapid [...]
CorVel Announces Fiscal Year Earnings Release Webcast
20/05/2019
IRVINE, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- Event: Fiscal Year Earnings Release Webcast Hosts: Michael Combs, President and Chief Executive Officer Brandon O’Brien, Chief Financial Officer Date: Thursday, May 30, [...]
Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update
20/05/2019
RUTHERFORD, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics, molecular markers and data [...]
Voyager Therapeutics Announces Management Updates
20/05/2019
CAMBRIDGE, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
SIGA Announces Exercise of Option for the Purchase of Raw Materials for Oral TPOXX® Manufacturing Totaling $11 Million
20/05/2019
Raw Materials expected to be used to Support Manufacture of 363,070 Courses of Oral TPOXX NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical [...]
B. Braun Interventional Systems Announces U.S. Commercial Launch of NuDEL™ All-in-One Stent Delivery System for Treatment of Congenital Heart Defects
20/05/2019
BETHLEHEM, Pa., May 20, 2019 (GLOBE NEWSWIRE) -- B. Braun Interventional Systems Inc. (BIS) in collaboration with NuMED Inc. announced today the U.S. launch of the NuDEL™ CP Stent ® Delivery System, intended for the [...]
Guardant Health, Inc. Announces Proposed Public Offering of Common Stock
20/05/2019
REDWOOD CITY, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.1%
20/05/2019
LAKE FOREST, Ill., May 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval [...]
Emergent BioSolutions Announces Granting of Marketing Authorization in Five EU Countries for Its Oral Typhoid Vaccine; Expands Availability Across Europe
20/05/2019
GAITHERSBURG, Md., May 20, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has successfully obtained marketing authorization for its oral typhoid vaccine Vivotif ® (Typhoid [...]
HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights
20/05/2019
NEW YORK and VIENNA, Austria, May 20, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary [...]
CymaBay Therapeutics Presents Data in Patients with Primary Biliary Cholangitis at DDW 2019
20/05/2019
NEWARK, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and [...]
Align Technology General Counsel Retires After 17 Years, Appoints Julie Coletti SVP Chief Legal and Regulatory Officer
20/05/2019
SAN JOSE, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), today announced that Roger E. George, Align senior vice president, chief legal and regulatory officer has retired and will leave [...]
AzurRx BioPharma Presents Positive Secondary Endpoint Data in its Phase II MS1819-SD Chronic Pancreatitis Study at the 2019 Digestive Disease Week Conference
20/05/2019
Statistical significance achieved on multiple secondary endpoints New data underscore the potential of MS1819 to provide meaningful clinical benefits to patients suffering from exocrine pancreatic insufficiency (EPI) [...]
Can-Fite BioPharma Announces $6 Million Registered Direct Offering
20/05/2019
PETACH TIKVA, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI) , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, [...]

Pages